Re: Farmas USA
OCAT
Do You Know the Top 5 iPS Cell Influencers (Right Now)?
The final award for the honor of iPSC industry influencer is given to Dr. Robert Lanza, Chief Scientific Officer of Ocata Therapeutics (previously Advanced Cell Therapeutics). He is honored both for his specific involvement in early-stage, pioneering iPSC research, as well as for his influence as the CSO of Ocata Therapeutics, a clinical-stage biotechnology company focused on commercialization of regenerative medicine and cell therapy technologies.
Ocata Therapeutics has shifted its induced pluripotent stem cell approach to producing iPSC derived human platelets. The benefit of a platelet-based product is that they do not contain nuclei, and therefore, cannot divide or carry genetic information. While nothing is risk-free, iPSC derived platelets remove the concern of uncontrolled proliferation. More recently, Ocata Therapeutics announced in March 2015 that it had entered into an agreement with Allele Biotechnology & Pharmaceuticals, Inc. to access Allele’s proprietary technology for generating human iPSCs.[7] The agreement is part of Ocata’s strategy to strengthen its regenerative ophthalmology technologies by using iPSCs to produce commercially viable human tissue for transplantation.
In addition, Dr. Lanza had been honored in 2013 by the Terrapin Group as one of the “Top 50 Global Stem Cell Influencers,” along with James Thomson and Nobel laureate Shinya Yamanaka, and has authored hundreds of research publications and books about stem cell related topics.
https://www.bioinformant.com/do-you-know-the-top-5-ips-cell-influencers-right-now/#more-2561
«Después de nada, o después de todo/ supe que todo no era más que nada.»
